b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30168416</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>22</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>22</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Print">0946-1965</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>56</Volume>\n                    <Issue>11</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Nov</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>International journal of clinical pharmacology and therapeutics</Title>\n                <ISOAbbreviation>Int J Clin Pharmacol Ther</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Bioequivalence study of the antiepileptic drug levetiracetam in concentrated solution for injection versus oral tablets in healthy Chinese subjects under fasting conditions: A randomized, open-label, three-way crossover study\xe2\x80\xa9.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>555-561</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.5414/CP203274</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this study was to evaluate the bioequivalence between single-dose intravenous (IV) infusion injection (the infusion time was 15 minutes and 45 minutes) and tablets of 1,000 mg levetiracetam in healthy Chinese male subjects.</AbstractText>\n                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This was a randomized, open-label, three-way crossover bioequivalence study. All of the 24 healthy male subjects received a treatment of 45-minute IV infusion, 15-minute IV infusion, and oral tablets.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">After a single dose, the AUC, V<sub>d</sub>, Cl, and T<sub>1/2</sub> were all essentially consistent among the treatment; t<sub>max</sub> of 15-minute IV, 45-minute IV, and oral tablets were 0.25 hours, 0.75 hours, and 0.5 hours, respectively. The C<sub>max</sub> of the 15-minute IV was higher than the value of the 45-minute IV and the oral tablets. The geometric mean of the 15-minute IV/oral and the 45-minute IV/oral ratios were 101.02% (90% CI, 98.95 - 103.12) and 98.22% (90% CI, 96.22 - 100.27), respectively, for AUC<sub>0-t</sub>. And those for C<sub>max</sub> were 169.09% (90% CI, 155.21 - 184.21) and 106.95 (90% CI, 98.20 - 116.48), respectively. There were no severe adverse events or other adverse events with clinical significance during the study.</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In these healthy subjects, the results showed that 45-minute IV and oral tablets were bioequivalent. The t&amp;lt;sub&amp;gt;max&amp;lt;/sub&amp;gt; of the 15-minute IV and oral tablets were significantly different. The t<sub>max</sub> of the oral tablets was between that of the 15-minute IV and the 45-minute IV. The elimination of injection and oral tablets in humans was similar. Levetiracetam concentrated solution for injection and oral tablets were safe for healthy Chinese male subjects in this study.\xe2\x80\xa9.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Xu</LastName>\n                    <ForeName>Junyu</ForeName>\n                    <Initials>J</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhao</LastName>\n                    <ForeName>Xia</ForeName>\n                    <Initials>X</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Zining</ForeName>\n                    <Initials>Z</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhou</LastName>\n                    <ForeName>Ying</ForeName>\n                    <Initials>Y</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yang</LastName>\n                    <ForeName>Xiaoqin</ForeName>\n                    <Initials>X</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cui</LastName>\n                    <ForeName>Yimin</ForeName>\n                    <Initials>Y</Initials>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D003160">Comparative Study</PublicationType>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>Int J Clin Pharmacol Ther</MedlineTA>\n            <NlmUniqueID>9423309</NlmUniqueID>\n            <ISSNLinking>0946-1965</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D019999">Pharmaceutical Solutions</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D013607">Tablets</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>44YRR34555</RegistryNumber>\n                <NameOfSubstance UI="D000077287">Levetiracetam</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001682" MajorTopicYN="N">Biological Availability</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006207" MajorTopicYN="N">Half-Life</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077287" MajorTopicYN="N">Levetiracetam</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019999" MajorTopicYN="N">Pharmaceutical Solutions</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013607" MajorTopicYN="N">Tablets</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013810" MajorTopicYN="N">Therapeutic Equivalency</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>23</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>9</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>9</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30168416</ArticleId>\n            <ArticleId IdType="pii">17567</ArticleId>\n            <ArticleId IdType="doi">10.5414/CP203274</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'